Isaac Ro analyst

Currently out of the existing stock ratings of Isaac Ro, 37 are a HOLD (46.25%), 35 are a BUY (43.75%), 8 are a SELL (10%).

Isaac Ro

Work Performance Price Targets & Ratings Chart

Analyst Isaac Ro, carries an average stock price target met ratio of 91.25% that have a potential upside of 19% achieved within 424 days. Previously, Isaac Ro worked at GOLDMAN SACHS.

Isaac Ro’s has documented 144 price targets and ratings displayed on 23 stocks. The coverage was on Healthcare, Industrials, Utilities sectors.

Most recent stock forecast was given on EXAS, EXACT Sciences at 12-Apr-2019.

Wall Street Analyst Isaac Ro

Analyst best performing recommendations are on ILMN (ILLUMINA).
The best stock recommendation documented was for ILMN (ILLUMINA) at 10/6/2015. The price target of $137 was fulfilled within 2 days with a profit of $4.84 (3.41%) receiving and performance score of 17.06.

Average potential price target upside

A Agilent Technologies DGX Quest Diagnostics DHR Danaher HOLX Hologic ISRG Intuitive Surgical MDT Medtronic PLC MYGN Myriad Genetics SRCL Stericycle TMO Thermo Fisher Scientific VAR Varian Medical Systems BSX Boston Scientific Corp ABT Abbott Laboratories PKI PerkinElmer ZBH Zimmer Biomet Holdings ALR Alerislife BAX Baxter International COO The Cooper Companies Common Stock DXCM DexCom ILMN Illumina LH Laboratory of America Holdings SR Spire EXAS EXACT Sciences NVRO Nevro Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Jul-2026

$135

$0.71 (0.53%)

$180

5 days ago
(09-Jul-2026)

7/10 (70%)

$1.41 (1.06%)

271

Buy Since 06-Apr-2026

$148

$13.71 (10.21%)

$140

8 days ago
(06-Jul-2026)

7/10 (70%)

$17.4 (13.32%)

27

Buy Since 26-Feb-2026

$150

$13.99 (10.29%)

$145

20 days ago
(24-Jun-2026)

16/22 (72.73%)

$18.37 (13.96%)

122

Buy Since 02-Jun-2026

$155

$18.99 (13.96%)

$145

1 months 12 days ago
(02-Jun-2026)

9/13 (69.23%)

$19.95 (14.77%)

164

Buy Since 24-May-2023

$155

$18.99 (13.96%)

$165

1 months 16 days ago
(28-May-2026)

15/20 (75%)

$19.62 (14.49%)

249

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Isaac Ro?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?